SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Jan-24 4:29 PM View: | Fate Therapeutics Inc (FATE) | 09-Jan-24 | Sale | 14,391 | $4.37 | $62,888.70 | (4%) 385.64K to 371.25K | |
11-Jan-23 4:09 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-23 | Sale | 45,907 | $5.24 | $240,553.00 | (11%) 431.55K to 385.64K | |
25-Jul-22 6:18 PM View: | Fate Therapeutics Inc (FATE) | 22-Jul-22 | Option Exercise | 6,246 | $2.70 | $16,864.20 | 1% 431.55K to 437.79K | |
25-Jul-22 6:18 PM View: | Fate Therapeutics Inc (FATE) | 22-Jul-22 | Planned Option Sale | 6,246 | $32.08 | $200,356.00 | (1%) 437.79K to 431.55K | |
25-Jul-22 6:18 PM View: | Fate Therapeutics Inc (FATE) | 21-Jul-22 | Option Exercise | 30,000 | $2.70 | $81,000.00 | 7% 431.55K to 461.55K | |
25-Jul-22 6:18 PM View: | Fate Therapeutics Inc (FATE) | 21-Jul-22 | Planned Option Sale | 30,000 | $32.88 | $986,361.00 | (6%) 461.55K to 431.55K | |
25-Apr-22 4:11 PM View: | Fate Therapeutics Inc (FATE) | 22-Apr-22 | Option Exercise | 10,000 | $2.70 | $27,000.00 | 2% 431.55K to 441.55K | |
25-Apr-22 4:11 PM View: | Fate Therapeutics Inc (FATE) | 22-Apr-22 | Planned Option Sale | 10,000 | $34.59 | $345,911.00 | (2%) 441.55K to 431.55K | |
25-Apr-22 4:11 PM View: | Fate Therapeutics Inc (FATE) | 21-Apr-22 | Option Exercise | 30,000 | $2.70 | $81,000.00 | 7% 431.55K to 461.55K | |
25-Apr-22 4:11 PM View: | Fate Therapeutics Inc (FATE) | 21-Apr-22 | Planned Option Sale | 30,000 | $35.00 | $1,049,880.00 | (6%) 461.55K to 431.55K | |
24-Jan-22 4:36 PM View: | Fate Therapeutics Inc (FATE) | 21-Jan-22 | Option Exercise | 10,000 | $2.70 | $27,000.00 | 2% 431.55K to 441.55K | |
24-Jan-22 4:36 PM View: | Fate Therapeutics Inc (FATE) | 21-Jan-22 | Planned Option Sale | 10,000 | $38.02 | $380,200.00 | (2%) 441.55K to 431.55K | |
24-Jan-22 4:36 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-22 | Option Exercise | 30,000 | $2.73 | $81,900.00 | 7% 431.55K to 461.55K | |
24-Jan-22 4:36 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-22 | Planned Option Sale | 30,000 | $40.21 | $1,206,300.00 | (6%) 461.55K to 431.55K | |
13-Jan-22 4:09 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-22 | Market Sale | 14,566 | $48.68 | $709,027.00 | (3%) 446.11K to 431.55K | (1%) |
12-Jan-22 4:07 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-22 | Market Sale | 34,156 | $46.86 | $1,600,530.00 | (7%) 480.27K to 446.11K | (5%) |
22-Nov-21 5:45 PM View: | Fate Therapeutics Inc (FATE) | 19-Nov-21 | Grant | 86,475 | -- | -- | 22% 393.79K to 480.27K | |
22-Nov-21 5:45 PM View: | Fate Therapeutics Inc (FATE) | 18-Nov-21 | Option Exercise | 20,000 | $2.70 | $54,000.00 | 5% 393.79K to 413.79K | |
22-Nov-21 5:45 PM View: | Fate Therapeutics Inc (FATE) | 18-Nov-21 | Market Option Sale (Planned) | 20,000 | $54.27 | $1,085,400.00 | (5%) 413.79K to 393.79K | |
25-Oct-21 4:04 PM View: | Fate Therapeutics Inc (FATE) | 22-Oct-21 | Option Exercise | 30,000 | $3.06 | $91,670.40 | 8% 393.79K to 423.79K | |
25-Oct-21 4:04 PM View: | Fate Therapeutics Inc (FATE) | 22-Oct-21 | Market Option Sale (Planned) | 30,000 | $58.88 | $1,766,400.00 | (7%) 423.79K to 393.79K | |
25-Oct-21 4:04 PM View: | Fate Therapeutics Inc (FATE) | 21-Oct-21 | Option Exercise | 30,000 | $2.73 | $81,900.00 | 8% 393.79K to 423.79K | |
25-Oct-21 4:04 PM View: | Fate Therapeutics Inc (FATE) | 21-Oct-21 | Market Option Sale (Planned) | 30,000 | $60.22 | $1,806,560.00 | (7%) 423.79K to 393.79K | |
26-Jul-21 4:05 PM View: | Fate Therapeutics Inc (FATE) | 23-Jul-21 | Option Exercise | 30,000 | $4.14 | $124,100.00 | 8% 393.79K to 423.79K | |
26-Jul-21 4:05 PM View: | Fate Therapeutics Inc (FATE) | 23-Jul-21 | Market Option Sale (Planned) | 30,000 | $85.28 | $2,558,540.00 | (7%) 423.79K to 393.79K | |
26-Jul-21 4:05 PM View: | Fate Therapeutics Inc (FATE) | 22-Jul-21 | Option Exercise | 30,000 | $2.73 | $81,900.00 | 8% 393.79K to 423.79K | |
26-Jul-21 4:05 PM View: | Fate Therapeutics Inc (FATE) | 22-Jul-21 | Market Option Sale (Planned) | 30,000 | $86.05 | $2,581,580.00 | (7%) 423.79K to 393.79K | |
24-May-21 4:01 PM View: | Fate Therapeutics Inc (FATE) | 20-May-21 | Option Exercise | 20,000 | $4.84 | $96,700.00 | 5% 393.79K to 413.79K | |
24-May-21 4:01 PM View: | Fate Therapeutics Inc (FATE) | 20-May-21 | Market Option Sale (Planned) | 20,000 | $77.16 | $1,543,290.00 | (5%) 413.79K to 393.79K | |
26-Apr-21 4:03 PM View: | Fate Therapeutics Inc (FATE) | 23-Apr-21 | Option Exercise | 30,000 | $5.02 | $150,500.00 | 8% 393.79K to 423.79K | |
26-Apr-21 4:03 PM View: | Fate Therapeutics Inc (FATE) | 23-Apr-21 | Market Option Sale (Planned) | 30,000 | $85.24 | $2,557,280.00 | (7%) 423.79K to 393.79K | |
26-Apr-21 4:03 PM View: | Fate Therapeutics Inc (FATE) | 22-Apr-21 | Option Exercise | 30,000 | $2.73 | $81,900.00 | 8% 393.79K to 423.79K | |
26-Apr-21 4:03 PM View: | Fate Therapeutics Inc (FATE) | 22-Apr-21 | Market Option Sale (Planned) | 30,000 | $85.54 | $2,566,210.00 | (7%) 423.79K to 393.79K | |
19-Feb-21 4:07 PM View: | Fate Therapeutics Inc (FATE) | 18-Feb-21 | Option Exercise | 20,000 | $6.62 | $132,400.00 | 5% 393.79K to 413.79K | |
19-Feb-21 4:07 PM View: | Fate Therapeutics Inc (FATE) | 18-Feb-21 | Market Option Sale (Planned) | 20,000 | $102.01 | $2,040,260.00 | (5%) 413.79K to 393.79K | |
22-Jan-21 6:23 PM View: | Fate Therapeutics Inc (FATE) | 22-Jan-21 | Option Exercise | 30,000 | $5.32 | $159,700.00 | 8% 393.79K to 423.79K | |
22-Jan-21 6:23 PM View: | Fate Therapeutics Inc (FATE) | 22-Jan-21 | Market Option Sale (Planned) | 30,000 | $98.29 | $2,948,610.00 | (7%) 423.79K to 393.79K | |
22-Jan-21 6:23 PM View: | Fate Therapeutics Inc (FATE) | 21-Jan-21 | Option Exercise | 30,000 | $2.73 | $81,900.00 | 8% 393.79K to 423.79K | |
22-Jan-21 6:23 PM View: | Fate Therapeutics Inc (FATE) | 21-Jan-21 | Market Option Sale (Planned) | 30,000 | $103.04 | $3,091,360.00 | (7%) 423.79K to 393.79K | |
22-Jan-21 6:23 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-21 | Grant | 43,231 | -- | -- | 12% 350.56K to 393.79K | |
12-Jan-21 8:41 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-21 | Market Sale | 8,587 | $110.81 | $951,556.00 | (2%) 359.15K to 350.56K | (1%) |
12-Jan-21 8:41 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-21 | Market Sale | 60,820 | $117.10 | $7,122,220.00 | (14%) 419.97K to 359.15K | 4% |
18-Dec-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 17-Dec-20 | Option Exercise | 20,000 | $6.62 | $132,400.00 | 5% 419.97K to 439.97K | |
18-Dec-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 17-Dec-20 | Market Option Sale (Planned) | 20,000 | $91.82 | $1,836,350.00 | (5%) 439.97K to 419.97K | (10%) |
16-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 13-Nov-20 | Option Exercise | 30,000 | $5.73 | $172,008.00 | 7% 419.97K to 449.97K | |
16-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 13-Nov-20 | Market Option Sale (Planned) | 30,000 | $51.03 | $1,530,900.00 | (7%) 449.97K to 419.97K | (98%) |
16-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 12-Nov-20 | Option Exercise | 30,000 | $2.73 | $81,900.00 | 7% 419.97K to 449.97K | |
16-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 12-Nov-20 | Market Option Sale (Planned) | 30,000 | $52.72 | $1,581,520.00 | (7%) 449.97K to 419.97K | (91%) |
03-Feb-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 30-Jan-20 | Option Exercise | 25,000 | $2.70 | $67,500.00 | 6% 419.97K to 444.97K | |
03-Feb-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 30-Jan-20 | Market Option Sale (Planned) | 25,000 | $25.45 | $636,302.00 | (6%) 444.97K to 419.97K | (296%) |